Revance Stock Today

RVNC Stock  USD 4.94  0.24  5.11%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 80

 
100  
 
Zero
High
Revance is trading at 4.94 as of the 28th of March 2024, a 5.11% increase since the beginning of the trading day. The stock's open price was 4.7. Revance has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Revance are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
6th of February 2014
Category
Healthcare
Classification
Health Care
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. Revance Therapeutics, Inc. The company has 104.22 M outstanding shares of which 10.87 M shares are at this time shorted by private and institutional investors with about 6.81 trading days to cover. More on Revance

Moving together with Revance Stock

  0.86MBRX Moleculin Biotech Upward RallyPairCorr
  0.7MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Revance Stock

  0.8MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.7DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.57MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.56MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.5EQ Equillium Financial Report 9th of May 2024 PairCorr

Revance Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Revance's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Revance or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO DirectorMark Foley
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Revance report their recommendations after researching Revance's financial statements, talking to executives and customers, or listening in on Revance's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Revance. The Revance consensus assessment is calculated by taking the average forecast from all of the analysts covering Revance.
Financial Strength
Based on the measurements of operating efficiency obtained from Revance's historical financial statements, Revance may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Revance is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.510.4892
Sufficiently Up
Slightly volatile
Total Current Liabilities51 M89.2 M
Way Down
Slightly volatile
Non Current Liabilities Total567.9 M540.8 M
Sufficiently Up
Slightly volatile
Total Assets331.9 M478.5 M
Way Down
Slightly volatile
Total Current Assets241.9 M338.9 M
Way Down
Slightly volatile
Revance's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Revance's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Revance's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Revance's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Revance's financial leverage. It provides some insight into what part of Revance's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Revance's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Revance deploys its capital and how much of that capital is borrowed.
Liquidity
Revance cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 478.43 M in liabilities with Debt to Equity (D/E) ratio of 2.94, implying the company greatly relies on financing operations through barrowing. Revance has a current ratio of 3.31, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Revance until it has trouble settling it off, either with new capital or with free cash flow. So, Revance's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Revance sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Revance to invest in growth at high rates of return. When we think about Revance's use of debt, we should always consider it together with cash and equity.

Stock Based Compensation

50.2 Million
Revance (RVNC) is traded on NASDAQ Exchange in USA. It is located in 1222 Demonbreun Street, Nashville, TN, United States, 37203 and employs 597 people. Revance is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 514.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Revance's market, we take the total number of its shares issued and multiply it by Revance's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Revance conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 104.22 M outstanding shares of which 10.87 M shares are at this time shorted by private and institutional investors with about 6.81 trading days to cover. Revance currently holds about 233.82 M in cash with (216.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.2.
Check Revance Probability Of Bankruptcy
Ownership Allocation
Revance has a total of 104.22 Million outstanding shares. The majority of Revance outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Revance to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Revance. Please pay attention to any change in the institutional holdings of Revance as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Revance Ownership Details

Revance Stock Price Odds Analysis

What are Revance's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Revance jumping above the current price in 90 days from now is about 85.29%. The Revance probability density function shows the probability of Revance stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.6053 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Revance will likely underperform. Additionally, revance has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 4.94HorizonTargetOdds Above 4.94
14.66%90 days
 4.94 
85.29%
Based on a normal probability distribution, the odds of Revance to move above the current price in 90 days from now is about 85.29 (This Revance probability density function shows the probability of Revance Stock to fall within a particular range of prices over 90 days) .

Revance Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Revance that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Revance's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Revance's value.
InstituionRecorded OnShares
Rubric Capital Management Lp2023-09-30
1.6 M
Point72 Asset Management, L.p.2023-09-30
1.4 M
Cibc Global Asset Management Inc2023-12-31
1.1 M
Goldman Sachs Group Inc2023-09-30
1.1 M
Jennison Associates Llc2023-12-31
M
Bamco Inc2023-12-31
M
Deerfield Management Co2023-09-30
870 K
Northern Trust Corp2023-09-30
838.4 K
D. E. Shaw & Co Lp2023-09-30
782 K
Capital World Investors2023-12-31
11.9 M
Blackrock Inc2023-12-31
7.5 M
View Revance Diagnostics

Revance Historical Income Statement

Revance Income Statement is one of the three primary financial statements used for reporting Revance's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Revance revenue and expense. Revance Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Revance's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 153.3 M, whereas Depreciation And Amortization is forecasted to decline to about 7.4 M. View More Fundamentals

Revance Stock Against Markets

Picking the right benchmark for Revance stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Revance stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Revance is critical whether you are bullish or bearish towards Revance at a given time. Please also check how Revance's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Revance without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Revance Corporate Directors

Revance corporate directors refer to members of a Revance board of directors. The board of directors generally takes responsibility for the Revance's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Revance's board members must vote for the resolution. The Revance board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jill BeraudDirectorProfile
Jeanie HerbertSr. Director of Investor RelationsProfile
Philip VickersIndependent DirectorProfile
Julian GangolliDirectorProfile

How to buy Revance Stock?

Before investing in Revance, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Revance. To buy Revance stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Revance. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Revance stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Revance stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Revance stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Revance, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Revance Stock please use our How to Invest in Revance guide.

Already Invested in Revance?

The danger of trading Revance is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Revance is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Revance. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Revance is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Revance Stock analysis

When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is Revance's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.83)
Revenue Per Share
2.766
Quarterly Revenue Growth
0.398
Return On Assets
(0.26)
Return On Equity
(20.97)
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.